Baidu Stock Drops Nearly 20% on $16.2B Impairment Shock
Baidu shares slumped after a hefty impairment charge underscored the heavy costs of its AI push, even as AI Cloud rev...
Earning cash on the spot is possible with the right strategies. Explore various ways to secure quick funds when needed.
20,121 articlesBaidu shares slumped after a hefty impairment charge underscored the heavy costs of its AI push, even as AI Cloud rev...
A wave of retirees is piling into ultra-high-yield ETFs, chasing income. Yet by measuring total return after taxes an...
When a york times reporter confronts a White House spokesperson, it isn’t just politics on display. It’s a teachable ...
Tesla faced a rocky period, but a few hopeful indicators suggest the EV leader may be on a steadier path. This articl...
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
Markets in 2026 push households to reexamine Ramsey’s disciplined framework. This article examines Dave Ramsey’s 5-St...
Today’s move in redwire stock popped today reflects a developing narrative around space infrastructure and NASA's new...
A rough week for stocks left many investors wonder what comes next. This guide breaks down why the Dow tumbled and th...
Nine months after Jim Cramer touted Energy Transfer as a top dividend pick for retirees, the stock has delivered on i...
AST SpaceMobile is set to unveil first-quarter results tonight. With a volatile backdrop and a slate of potential cat...
A stunning earnings moment has sparked questions about AMD's role in AI infrastructure. This deep-dive breaks down wh...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...